The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles Y Deng, JK Saucier-Sawyer, CJ Hoimes, J Zhang, YE Seo, ... Biomaterials 35 (24), 6595-6602, 2014 | 154 | 2014 |
Cellular distribution of injected PLGA-nanoparticles in the liver JK Park, T Utsumi, YE Seo, Y Deng, A Satoh, WM Saltzman, Y Iwakiri Nanomedicine: Nanotechnology, Biology and Medicine 12 (5), 1365-1374, 2016 | 129 | 2016 |
Cell penetrating peptide-modified poly (lactic-co-glycolic acid) nanoparticles with enhanced cell internalization JM Steinbach, YE Seo, WM Saltzman Acta biomaterialia 30, 49-61, 2016 | 100 | 2016 |
Surface chemistry governs cellular tropism of nanoparticles in the brain E Song, A Gaudin, AR King, YE Seo, HW Suh, Y Deng, J Cui, GT Tietjen, ... Nature communications 8 (1), 15322, 2017 | 92 | 2017 |
Systemic delivery of blood–brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue JK Saucier-Sawyer, Y Deng, YE Seo, CJ Cheng, J Zhang, E Quijano, ... Journal of drug targeting 23 (7-8), 736-749, 2015 | 89 | 2015 |
Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma YE Seo, HW Suh, R Bahal, A Josowitz, J Zhang, E Song, J Cui, ... Biomaterials 201, 87-98, 2019 | 84 | 2019 |
Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors JK Saucier-Sawyer, YE Seo, A Gaudin, E Quijano, E Song, AJ Sawyer, ... Journal of Controlled Release 232, 103-112, 2016 | 80 | 2016 |
Biodegradable PEG-poly (ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors EM Chen, AR Quijano, YE Seo, C Jackson, AD Josowitz, S Noorbakhsh, ... Biomaterials 178, 193-203, 2018 | 50 | 2018 |
FrzS regulates social motility in Myxococcus xanthus by controlling exopolysaccharide production JE Berleman, JJ Vicente, AE Davis, SY Jiang, YE Seo, DR Zusman PloS one 6 (8), e23920, 2011 | 45 | 2011 |
Nanomaterials for convection-enhanced delivery of agents to treat brain tumors YE Seo, T Bu, WM Saltzman Current opinion in biomedical engineering 4, 1-12, 2017 | 32 | 2017 |
Poly (amine-co-ester) nanoparticles for effective Nogo-B knockdown in the liver J Cui, AS Piotrowski-Daspit, J Zhang, M Shao, LG Bracaglia, T Utsumi, ... Journal of controlled release 304, 259-267, 2019 | 27 | 2019 |
Enhancing potency of siRNA targeting fusion genes by optimization outside of target sequence K Gavrilov, YE Seo, GT Tietjen, J Cui, CJ Cheng, WM Saltzman Proceedings of the National Academy of Sciences 112 (48), E6597-E6605, 2015 | 16 | 2015 |
Systemic γ-sarcoglycan AAV gene transfer results in dose-dependent correction of muscle deficits in the LGMD 2C/R5 mouse model YE Seo, SH Baine, AN Kempton, OC Rogers, S Lewis, K Adegboye, ... Molecular Therapy Methods & Clinical Development 28, 284-299, 2023 | 8 | 2023 |
Systemic dose-finding study with AAV-Mediated gamma-sarcoglycan gene therapy for treatment of muscle deficits in LGMD2C Mice Y Seo, A Kempton, O Rogers, S Baine, S Lewis, K Adegboye, A Haile, ... NEUROMUSCULAR DISORDERS 30, S87-S87, 2020 | 1 | 2020 |
4.30 Nanomaterials for Drug Delivery to the Brain A Gaudin, YE Seo, E Song, E Quijano, AR King, WM Saltzman Elsevier, 2017 | 1 | 2017 |
LIMB GIRDLE MUSCULAR DYSTROPHIES: P. 138 Systemic dose-finding study with AAV-Mediated gamma-sarcoglycan gene therapy for treatment of muscle deficits in LGMD2C Mice Y Seo, A Kempton, O Rogers, S Baine, S Lewis, K Adegboye, A Haile, ... Neuromuscular Disorders 30, S87, 2020 | | 2020 |
LIMB GIRDLE MUSCULAR DYSTROPHIES: P. 137 Treatment of aged mice and long-term durability of AAV-mediated gene therapy in two mouse models of Limb girdle muscular dystrophy E Pozsgai, D Griffin, E Peterson, A Kempton, O Rogers, Y Seo, ... Neuromuscular Disorders 30, S86-S87, 2020 | | 2020 |
LIMB GIRDLE MUSCULAR DYSTROPHIES: P. 139 Expression-functional correlation and validation of a surrogate marker for DAPC restoration in LGMD2E mouse model E Pozsgai, E Peterson, A Kempton, O Rogers, Y Seo, L Rodino-Klapac Neuromuscular Disorders 30, S87, 2020 | | 2020 |
Treatment of aged mice and long-term durability of AAV-mediated gene therapy in two mouse models of Limb girdle muscular dystrophy E Pozsgai, D Griffin, E Peterson, A Kempton, O Rogers, Y Seo, ... NEUROMUSCULAR DISORDERS 30, S86-S87, 2020 | | 2020 |
Treatment of Aged Mice and Long-term Durability of AAV-Mediated Gene Therapy in Two Mouse Models of LGMD ER Pozsgai, DA Griffin, EL Peterson, A Kempton, O Rogers, YE Seo, ... Presented at ASGCT 23rd Annual Meeting| May 12, 15, 2020 | | 2020 |